Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Rankning i aktier #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Aktiekurs
$44.60
Marknadsvärde
$108.62B
Förändring (1 dag)
-1.63%
Förändring (1 år)
-21.62%
Land
FR
Handel Sanofi (SNY)

Kategori

Vinst för Sanofi (SNY)
Vinst i Dec 2025 TTM: $7.06B
Enligt de senaste finansiella rapporterna från Sanofi är företagets nuvarande vinst $7.06B. År 2024 hade företaget en vinst på $7.03B, en ökning jämfört med vinsten år 2023 som var $6.76B. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Sanofi från 2000 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $7.06B 0.00%
2025 $7.06B 0.44%
2024 $7.03B 4.03%
2023 $6.76B -36.93%
2022 $10.72B 20.27%
2021 $8.91B -48.24%
2020 $17.22B 410.31%
2019 $3.37B -40.13%
2018 $5.64B -16.37%
2017 $6.74B 10.21%
2016 $6.11B 7.85%
2015 $5.67B -16.42%
2014 $6.78B 9.05%
2013 $6.22B -23.52%
2012 $8.13B -0.71%
2011 $8.19B -14.33%
2010 $9.56B -3.08%
2009 $9.87B 45.83%
2008 $6.76B -25.57%
2007 $9.09B 43.73%
2006 $6.32B 95.83%
2005 $3.23B -3.31%
2004 $3.34B -15.22%
2003 $3.94B 49.74%
2002 $2.63B 21.90%
2001 $2.16B 43.20%
2000 $1.51B 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$25.73B 264.29%
US
$12.40B 75.59%
GB
$32.58B 361.29%
US
$6.60B -6.60%
US
$16.35B 131.51%
CH